General Health Care Authority rulemaking

This page includes all of the current rule making activity for General Health Care Authority.

Description
The agency is amending this rule to add language about data sharing between the prescription drug affordability board and the health care cost transparency board to align with Engrossed Substitute House Bill 1508, Chapter 80, Laws of 2024, Sec. 2, (2)(a). Additionally, the agency may add a new section regarding a time frame of 30 days for public comment prior to the board setting an upper payment limit to align with Substitute House Bill 1105, Chapter 171, Laws of 2024, Sec. 1, (1).

Agency contacts

Rulemaking contact

Valerie Freudenstein

Program contact

Mike Neuenschwander

Rulemaking status history

Preproposal (CR101)

Description
The agency is amending WAC 182-50-030 to permit members of the pharmacy and therapeutics committee to serve for up to three consecutive three-year terms.

Agency contacts

Rulemaking contact

Brian Jensen

Program contact

Leta Evaskus

Rulemaking status history

Preproposal (CR101)

Proposal (CR102)

Description
To implement the Prescription Drug Affordability Board as required in SSSB 5532, Chapter 153, Laws of 2022.

Agency contacts

Rulemaking contact

Valerie Freudenstein

Program contact

Mike Neuenschwander

Rulemaking status history

Preproposal (CR101)

Proposal (CR102)

  • WSR 23-21-082
  • Hearing Date and Comments due by: 11/21/2023
  • Registration required: https://us02web.zoom.us/webinar/register/WN_F8flPPyoSyqDs-EZHwgrLQ

Permanent Adoption (CR103P)